TG Therapeutics | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 1.46B 1.86B 2025-03
Alaunos Therapeutics USD 2.06M 661K 2024-12
Amgen USD 6.21B 330M 2025-03
Ardelyx USD 173.29M 14.99M 2024-12
Arrowhead Research USD 522.31M 161.91M 2025-06
Bayer EUR 32.58B 537M 2025-03
Biogen USD 17.63B 655.3M 2025-06
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Dynavax Technologies USD 494.16M 36.78M 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
J&J USD 78.11B 6.62B 2025-03
Novartis USD 42.05B 3.6B 2025-06
PTC Therapeutics USD -206546000 20.79M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
TG Therapeutics USD 237.29M 14.92M 2025-03
Vertex Pharmaceuticals USD 16.5B 86.7M 2025-03


TG Therapeutics Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.